PA
VERA icon

Parallel Advisors’s Vera Therapeutics VERA Stock Holding History

Parallel Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75K Hold
64
– – ﹤0.01% 3438
2026
Q1 		$2.58K Sell
64
-258
-80% -$11.1K ﹤0.01% 3288
2025
Q4 		$16.3K Buy
322
+23
+8% +$817 ﹤0.01% 2398
2025
Q3 		$8.69K Buy
+299
New +$6.92K ﹤0.01% 2580
2025
Q1 		– Sell
-2
Closed -$85 – 3678
2024
Q4 		$85 Sell
2
-13
-87% -$576 ﹤0.01% 3454
2024
Q3 		$663 Buy
+15
New +$569 ﹤0.01% 3128

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parallel Advisors's VERA Position: Q2 2026 in Review

Parallel Advisors held its Vera Therapeutics (VERA) position steady in Q2 2026 at 64 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3438.

Parallel Advisors first reported a position in VERA in Q3 2024 and has held it in 6 quarters since. The position peaked at $16.3K in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Parallel Advisors held 64 shares of Vera Therapeutics worth $2.75K as of Q2 2026.
  • Parallel Advisors left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3438 holding.
  • Parallel Advisors first reported a position in Vera Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • Parallel Advisors's Vera Therapeutics position peaked at $16.3K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.